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Abstract: Human immunodeficiency virus 1 (HIV-1) infects T cells, macrophages and 
dendritic cells and can manipulate their cytoskeleton structures at multiple steps during its 
replication cycle. Based on pharmacological and genetic targeting of cytoskeleton 
modulators, new imaging approaches and primary cell culture models, important roles for 
actin and microtubules during entry and cell-to-cell transfer have been established. 
Virological synapses and actin-containing membrane extensions can mediate HIV-1 
transfer from dendritic cells or macrophage cells to T cells and between T cells. We will 
review the role of the cytoskeleton in HIV-1 entry, cellular trafficking and cell-to-cell 
transfer between primary cells.  
Keywords: HIV-1; actin; microtubules; virological synapse; dendritic cells; cell-to-cell 
transfer 
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1. Introduction 
The cytoskeleton supports mechanical stability of the cell, enables its movement, division and 
intracellular organelle transport by way of three types of filaments: intermediate filaments, actin and 
microtubules. Intermediate filaments form dynamic cellular networks that provide mechanical stability 
and position intracellular organelles [1]. Monomers of microtubules and actin assemble into polar 
filaments that can be used as tracks by plus and minus end motor proteins. Kinesins and dynein are 
microtubule motors that mediate long range outward and inward transport, respectively. On the   
other hand, short range transport at the cell periphery involves myosin motor proteins moving on  
actin filaments [2].  
For viruses that enter the cytoplasm through fusion at the plasma membrane, the cytoskeleton can 
represent an additional mechanical barrier. Subsequent diffusion of subviral particles larger than 
500 kDa is restricted in the cytoplasm, so host cytoskeleton-associated motor proteins can be used for 
active transport of the genome to the nucleus for replication [3]. Transport of Adenovirus and Herpes 
simplex virus genomes to the nucleus relies on active transport on microtubules [4]. To efficiently 
infect neurons, Herpes simplex virus uses kinesins and dynein to move along the microtubules within 
dendrites or axons and spread through neuronal synapses [3,5]. At late stages of infection, Vaccinia 
virus induces actin tails that efficiently propel enveloped viral particles towards uninfected cells [6]. 
Furthermore, viruses can use alternative mechanisms, such as actin-rich cell surface structures and 
cell-to-cell contacts, for efficient viral dissemination [7]. 
Human immunodeficiency virus 1 (HIV-1) infects cells of the immune system, namely CD4 T cells, 
macrophages and dendritic cells (DCs). In order to efficiently enter these cells, HIV-1 has to recruit its 
fusion receptors, overcome the cortical actin cytoskeleton and transport its genome to the nucleus. 
Immune cells are mobile and exchange information during antigen presentation via cellular contacts, 
notably immunological synapses. Similarly, HIV-1 can efficiently spread between immune cells using 
close cell-contacts called virological synapses (VS) [8].  
Here we will discuss how HIV-1 manipulates the cytoskeleton during entry, replication and cell-to-
cell transmission using VS and transfer on membrane extensions. Whenever possible we will focus on 
data from most relevant primary cells.  
2. The Role of the Cytoskeleton in HIV-1 Replication 
2.1. Entry  
To initiate viral membrane fusion the gp120 part of the HIV-1 envelope (Env) interacts sequentially 
with the primary receptor CD4 and coreceptor CXCR4 or CCR5, which leads to the exposure of the 
fusion promoting peptide of the gp41 part of Env [9]. Early studies indicated that the binding of HIV-1 
Env to CD4 induces clustering of CD4 and CXCR4. CD4/CXCR4 clustering was dependent on actin 
polymerization and is required for entry and infection [10]. Similar dependency on the actin 
cytoskeleton was more recently described for CCR5 clustering [11]. Only recently it was shown that 
Env-dependent actin remodeling involves the actin-crosslinker Filamin-A, Rho-A and Rac guanosine-
triphosphatases (GTPase) and actin-depolymerization factor cofilin (Figure 1). The actin-crosslinking 
protein Filamin-A binds the cytoplasmic tails of CD4 and CXCR4 and subsequent Env-dependent Viruses 2011, 3                  
 
 
1759
signaling leads to the activation of Rho-A [11] and Rac1 [12]. Both Rho-A and Rac GTPase activate 
LIM domain kinase, which phosphorylates and inactivates cofilin. Inactive cofilin triggers early actin 
polymerization and receptor clustering [11,12]. In addition, Env-binding to CD4 activates moesin of 
the ezrin/radixin/moesin (ERM) complex that promotes CD4/CXCR4 clustering [13]. Active ERM 
complex tethers transmembrane and cytoplasmic proteins to filamentous actin (F-actin) and promotes 
its membrane recruitment.  
While recruitment of sufficient receptor/coreceptor complexes through actin polymerization is 
required to initiate fusion, the cortical actin—although a highly dynamic network—could pose a 
barrier to fusion pore enlargement and the passage of the capsid into the cytoplasm [14–16]. 
Env binding to CXCR4 induces signaling and promotes actin remodeling critical for viral intracellular 
entry. Activation of cofilin, an actin depolymerization factor, is required to overcome the cortical actin 
barrier in resting T cells [14]. Furthermore, Env signaling through CXCR4 activates Rac1-GTPase, 
which promotes fusion pore formation and entry via Wave2 and the actin-nucleation factor   
Arp2/3 [16–18].  
The precise recruitment and activation of the different actin remodeling factors upon Env 
signaling via CD4 and coreceptor remains to be determined. Likewise, Env signaling upstream of the  
Rho-A/ Rac-LIMK-cofilin pathway and the kinase that phosphorylates moesin in the ERM complex 
have still to be ascertained. Furthermore, it is not yet clear whether Env induced receptor clustering 
results from centripetal actin flow generated by myosin motors or reflects a simple diffusion-capture 
mechanism [19].  
In order to follow Env-dependent signaling and actin remodeling dynamically in vivo, recently 
developed fluorescent probes such as Rho/Rac GTPase-biosensors [20] and the fluorescent actin-probe 
lifeact [21] could be useful. Super-resolution microscopy can resolve and track single molecules in 
living cells with 20–40 nm resolution [22] and could provide detailed insight into actin-remodeling 
upon single virus binding events.  
HIV-1 Nef, a small myristoylated protein also affects early post-fusion steps leading to increased 
infectivity [23,24]. The defect in infectivity of Nef-deficient HIV-1 can be complemented by 
disruption of the actin cytoskeleton [15] or by pseudotyping virions with Vesicular Stomatitis Virus 
glycoprotein (VSV-G) that fuses in low pH endocytotic vesicles. 
Dynamin-2 and clathrin, both regulators of vesicular trafficking, are required in producer cells to 
observe the effect of Nef on infectivity [25]. By affecting clathrin-dependent endocytosis Nef could 
change the lipid composition of virions [25] and/or specifically remove a host factor from virions that 
limits fusion pore enlargement and passage of the viral core through the cortical actin cytoskeleton.  
Productive infection of CD4 T cells mainly occurs through fusion at the plasma membrane [9,26]. 
Alternatively, HIV-1 could enter and infect cells via endocytosis and subsequent fusion with 
endosomal membranes [27–32]. HIV-1 may take distinct endocytotic routes in different cell types.  
Clathrin-mediated endocytosis of HIV-1 was observed in HeLa cells and in primary and 
transformed T cells [27,28,30]. HIV-1 pseudotyped with VSV-G allows CD4/coreceptor independent 
entry through endocytosis in various cell types, including transformed T cells. On the contrary, 
infection of resting primary CD4-T cells required HIV-1 Env but not VSV-G, indicating the 
importance of HIV-1 Env signaling and actin remodeling in relevant primary cells [33].  Viruses 2011, 3                  
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Figure 1. Simplified model of the role of the cytoskeleton in HIV-1 entry and release. 
(a)  Binding of HIV-1 Env to CD4/CXCR4 and signaling leads to transient actin 
polymerization and receptor clustering through Filamin-A dependent crosslinking of 
CD4/CXCR4, activation of the ezrin/radixin/moesin (ERM) complex and inactivation of 
Cofilin. Subsequent actin depolymerization and fusion pore formation requires CXCR4 
signaling to activate cofilin and Arp2/3. Viral cores can be transported on microtubules or 
actin towards the nucleus. Alternatively, HIV-1 enters through endocytosis and fuses 
with  intracellular vesicles. (b)  Usually HIV-1 assembles at the plasma membrane of   
non-polarized cells independently of the cytoskeleton. Note that transport of Env through 
the secretory pathway is not depicted. (c) Assembly of HIV-1 in polarized T cells occurs at 
actin rich pseudo-pod structures with a polarized microtubule organizing center (MTOC). 
(d) Assembly in chronically infected macrophages occurs at invaginated regions of the 
plasma membrane enriched in tetraspanins which are stabilized by the actin cytoskeleton.  
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Uptake into DCs requires macropinocytosis, intact actin filaments and microtubules, but their role 
in productive infections has not been determined [34,35]. DCs capture HIV-1 through the C-type lectin 
DC-SIGN and preserve infectious virions inside internal compartments enriched in actin and 
tetraspanins [35,36]. Conversely Langerhans cells, an epidermal subtype of DCs, capture virions via 
the C-type lectin langerin and efficiently degrade HIV-1 [37].  
HIV-1 enters and infects macrophages following dynamin-dependent macropinocytosis, which in 
contrast to classical macropinocytosis, does not require myosin II and vesicle acidification [29,31].  
Entry pathways in primary cells have only been characterized using a few pharmacological 
inhibitors that may have possible non-specific effects. Thus, the role of endocytosis in productive 
infection should be confirmed by genetic strategies using RNAi or dominant negative constructs. 
Transduction of primary macrophages and DCs by HIV-1-derived lentiviral vectors is highly effective 
in the presence of vpx [38]. 
Overall, entry through endocytosis is advantageous for the virus as it minimizes its contact with 
neutralizing antibodies, enables passage through the cortical actin cytoskeleton and retrograde 
transport towards the nucleus. Nevertheless the virus has to escape lysosomal degradation, especially 
in professional phagocytotic cells, like macrophages and DCs. Therefore, as recently proposed, cell 
type specific entry receptor levels, Env fusion kinetics and endocytosis rates can determine whether 
fusion occurs at the plasma-membrane or from endosomes [39]. 
2.2. Intracellular Transport  
Cell fractionation has shown that the reverse transcription of viral RNA in the cytoplasm relies on 
interactions of the HIV-1 core with the actin cytoskeleton [40]. Live-cell microscopy revealed actin 
and microtubule-dependent movements of fluorescently-labeled HIV-1 [41,42]. Pharmacological 
inhibition of actin and microtubule polymerization arrested overall movements. Moreover, specific 
antibodies against dynein or genetic targeting of the dynein activator complex, dynactin, blocked 
minus-end transport of the particles towards the nucleus [41,42]. At the nuclear periphery, the   
pre-integration complex associates with perinuclear actin and eventually enters the nucleus [42]. Of 
note, both studies used adhered cells with a large cytoplasm and well defined microtubules. In contrast, 
in transformed and resting CD4 T cells microtubule integrity was not required for infection [43], 
indicating that short cytoplasmic distances in T cells can be overcome by actin-dependent transport. 
Nevertheless, microtubule-dependent transport might be necessary for the infection of adhered 
macrophages and dendritic cells. 
Overall, it remains unclear how the viral genome is transported, uncoated and reverse transcribed 
and how these processes are coordinated. Notably, these steps in the HIV-1 life-cycle are sensitive to 
potent host restriction factors Apobec3G, TRIM5 and SAMHD1 [44–47] and their mechanisms should 
be better characterized.  
2.3. Assembly and Budding 
The transport of newly synthesized viral proteins towards assembly sites occurs via the secretory 
pathway for HIV-1 Env and via diffusion for HIV-1 Gag [9,48].  Viruses 2011, 3                  
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During assembly, HIV-1 Gag binds F-actin via its nucleocapsid region [49,50]. Actin, myosin and 
actin-binding proteins were found at assembly sites and inside virions [51–53]. During HIV-1 budding 
star-shaped actin structures formed when the nucleocapsid region of Gag was present [54]. Despite the 
interaction of actin and HIV-1 Gag, pharmacological inhibitors of actin and microtubule assembly only 
slightly decreased or did not affect HIV-1 release from cell lines and primary cells [10,53,55,56]. 
Therefore, the cytoskeleton seems not to be required for HIV-1 assembly and release from the plasma 
membrane of infected cells.  
In polarized T cells and monocytes, HIV-1 budding was observed at polarized caps or cell 
protrusions (Figure 1c) [57–59]. At this actin-rich uropod structure HIV-1 Env and Gag colocalize 
with GM1 lipid rafts, tetraspanins and adhesion molecules [55,60–62]. Gag localization to the uropod 
is Env independent, but requires an intact Gag nucleocapsid part. The uropod structures copolarized 
with the MTOC and polarized Gag was sensitive to inhibitors of actin, myosin and microtubules, 
indicating a possible role of the cytoskeleton in targeted secretion and polarized budding [55,62].  
In HIV-1 infected macrophages and DCs, assembly was observed on internal compartments that 
were subsequently identified as tetraspanin-rich sequestered plasma membrane domains [63–67]. The 
disruption of the actin cytoskeleton in infected macrophages decreased intracellular accumulation of 
HIV-1, but had no effect on the overall release [56].  
Therefore, despite interaction of HIV-1 Gag with actin, there is no direct functional role of the 
cytoskeleton in HIV-1 assembly. Nevertheless, polarized budding at T cell uropods and intracellular 
budding in macrophages both depend on the cytoskeleton. The local concentration of virus at the 
uropod or in an intracellular compartment could facilitate subsequent cell-to-cell spread of HIV-1. 
3. Role of Cytoskeleton in Cell-to-Cell Transfer between T Cells 
3.1. HIV-1 Transmission  
HIV-1 can spread between hosts through sexual transmission of cell-free or cell-associated virus. 
Major efforts are directed into the development of microbicides blocking the early steps of viral 
transmission at the mucosa [68]. Following entry, HIV-1 encounters potential target cells [69,70]. CD4 
T cells can be directly infected in mucosal tissue [71]. Otherwise, HIV-1 can be taken up by APCs, 
such as dermal DCs, Langerhans cells (LC) and macrophages [69]. LC can transfer captured virus to 
resident T cells [71]. Alternatively, APCs can exit the mucosa and migrate to proximal lymph nodes, 
where captured and newly replicated virus can be transferred to T cells [70,72,73]. 
Cell-to-cell transfer can provide several advantages over cell free infection. (i) HIV-1 could escape 
detection by neutralizing antibodies, (ii) close contact limits diffusion time to a new target cell, and 
(iii) the VS concentrates virus and viral entry receptors to increase fusion efficiency. HIV-1 infection 
through cell-to-cell transfer was shown to be 100- to 18,000-times more effective than through   
cell-free virus [57,74]. Protection from neutralizing antibodies at the HIV-1 VS was initially observed 
[26,32,57], but recently challenged by another study [75]. Efficient HIV-1 cell-to-cell transfer takes 
place at cell-contacts called the VS, that was observed between: (i) HIV-1 pulsed DCs and T cells, 
(ii) infected and uninfected T cells, and (iii) infected macrophages and T cells [26,73,76,77]. Since Viruses 2011, 3                  
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virological synapses are cell contacts formed between different types of immune cells, analogies to 
antigen presentation at the immunological synapses were proposed [26,76,78].  
Immunological synapses (IS) are specialized cell contacts either between antigen-presenting cells 
(APCs) and T cells or between target cells and effector T cells (Figure 2a). APCs can activate T cells 
which upon clonal expansion can execute effector functions, such as cytokine release or directed 
cytolysis. Peptide-major histocompatibility complex (pMHC) on the APCs engage a specific T-cell 
receptor (TCR), CD4 and kinases into an actin-dependent microcluster. TCR microcluster converge 
towards the central supramolecular activation complex (cSMAC), where TCR signaling is terminated. 
The cSMAC is surrounded by a ring of adhesion molecules and is associated with talin and F-actin. 
This peripheral SMAC (pSMAC) stabilizes the IS. The duration of the IS can be transient or last for 
hours. Strong pMHC-TCR affinity and costimulatory signals lead to polarization of the MTOC 
towards the APC and full activation of the T-cell. Cytoskeleton remodeling during T-cell activation 
was extensively reviewed recently [79].  
3.2. The Virological Synapse  
The structure of the VS and the mechanism of transfer are best characterized in the T cell context, 
but are similar in APC-T cell VS (Figure 2b). 
Mobile monocytes and lymphocytes form membrane extensions at their rear, called uropods. The 
uropod is rich in cytoskeleton and adhesion molecules, can mediate cell-to-cell contacts and support 
polarized HIV-1 assembly [57–59,62]. Both polarized budding and cell-to-cell transfer depend on the 
actin and the microtubule cytoskeleton [26,32,55,80]. Therefore, the cytoskeleton could facilitate cell 
contacts, VS formation and cell-to-cell transfer through polarized budding.  
The VS forms between a HIV-1 infected and uninfected cells via Env interactions with CD4 and 
CXCR4 or CCR5. Env and Gag concentrate on the infected cell, leading to polarized budding and 
transfer of virions across the VS [26,32]. On the target cell CD4 and coreceptor polarize towards the 
VS, thereby increasing the probability of virus fusion and the strength of the cell contact. 
Additional stability to the virological synapse is conferred by adhesion molecules. Intercellular 
adhesion molecule 1 (ICAM-1) or ICAM-3 on the infected cell interact with the integrin lymphocyte 
function-associated antigen 1 (LFA-1) on the target cell [81]. Talin, an actin-bridging molecule, 
interacts with LFA-1 and thereby reorganizes F-actin in the target cell. Adhesion molecules, talin and 
F-actin form a stable ring-like structure, resembling the pSMAC [26,80,81]. Pharmacological 
inhibition of actin remodeling and myosin-dependent transport in target cells inhibited CD4, CXCR4 
and Env clustering and transfer of infection at the VS [26,57].  
Recently, live-cell imaging of CD4 T cells interacting with planar lipid bilayers containing HIV-1 
Env and ICAM-1 provided a detailed structural and dynamic view of the VS [78,82,83]. Upon contact 
with CD4 T cells, Env forms an actin-dependent microcluster. The microclusters converge into the 
cSMAC and reorganize CD4 on the target cell. The CD4/Env containing cSMAC, surrounded by a 
ring of adhesion molecules and F-actin, transiently arrests T-cell migration [83]. Furthermore, 
Env  induces partial TCR signaling that activates Lck and creates an F-actin depleted zone at the 
cSMAC [82]. Notably, some TCR recruitment and F-actin depletion from the center of the VS were 
also apparent in authentic T-cell contacts [26]. However, the absence of Zap70, the key mediator of Viruses 2011, 3                  
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TCR signaling, in target T cells does not affect HIV-1 transfer [82]. Therefore, it remains unclear if 
TCR signaling is required for VS formation and how Lck activation leads to depletion of F-actin from 
the central zone of the VS.  
Alternatively, actin remodeling during the formation of the VS could also implicate Filamin-A or 
Env-dependent activation of ERM, Arp2/3 and cofilin as discussed before [19]. Env expressing cells 
induce Filamin-A dependent clustering of CD4 and CXCR4/CCR5 on target cells [11]. The role of 
Filamin-A, Lck, ERM, Arp2/3 and cofilin in Env-dependent signaling and actin remodeling in 
authentic VS needs further detailed investigation. The simplified lipid-bilayer system of the VS 
combined with high-resolution live-cell microscopy [84] or super-resolution techniques [22,85] could 
answer these questions and reveal how actin is dynamically remodeled.  
HIV-1 transfer through VS relies on intact microtubules [55,80]. During transfer the microtubule 
organizing centre (MTOC) in HIV-1 infected T cells, but not in target cells polarizes towards the 
VS [7,82,86]. As expected, in infected T cells that engage multiple target cells through polysynapses 
the MTOC polarizes only to an individual synapse [80]. Zap70, a key mediator of TCR signaling and 
MTOC polarization, is required for VS formation and HIV-1 transfer. HIV-1 infected donor cells 
lacking Zap70 show defects in MTOC polarization and VS formation, but release normal amounts of 
infectious virus and establish conjugates with uninfected cells [86]. Therefore, the microtubule 
network may be involved in targeted secretion of viral components, adhesion molecules, tetraspanins 
or specific lipids to the VS that favor directed budding towards the target cell [87]. Once a stable VS is 
formed, the MTOC could initiate additional cell contacts leading to polysynapses.  
Alternatively, polarized budding at the VS could result from incorporation of locally concentrated 
Env in virus particles that depend on the cytoplasmic tail (CT) of HIV-1 Env [9]. HIV-1 Env lacking 
the CT increases cell-to-cell transfer, but is more neutralization-sensitive than full-length Env [57]. 
Mouse Leukemia virus (MLV) Env concentrates at the cell-to-cell contact through interaction with 
receptors, interacts with MLV Gag via its cytoplasmic tail (CT) and could initiate polarized 
budding [88,89]. How the cytoskeleton and HIV-1 Env polarization affects polarized budding at the 
VS remains an important question for the future. 
Dynamic imaging of the T-cell VS revealed HIV-1 Gag in button-shaped discs or ring like 
structures with Gag patches migrating into the synapse and transfer of viral aggregates [32,80]. 
Therefore, VS can provide stable contacts lasting minutes to hours that would allow polarized budding 
at the contact and transfer of virus from distal assembly sites. The attachment factor and details of 
HIV-1 movement on infected cells prior to transfer remain to be determined [89,90].  
3.3. Actin-Containing Membrane Protrusions  
Besides VS actin-containing membrane extensions, filopodial bridges, nanotubes and 
tunneling  nanotubes have been implicated in cell-to-cell transfer of HIV-1 (Figure 2c) and other 
retroviruses  [80,91–93]. Filopodial bridges extend from uninfected to infected epithelial cells, are 
stabilized through Env-receptor interaction and mediate viral transfer through retrograde actin flow 
towards the uninfected cell [91]. Nanotubes, on the other hand, are formed upon transient contact 
between T cells and connect cells over several cell lengths in curved paths. HIV-1 infection did not 
affect the frequency nor the direction of intercellular connections through nanotubes, but infection of Viruses 2011, 3                  
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target cells occurred in a receptor-dependent manner [92]. Tunneling nanotubes, however, are induced 
by HIV-1 infection of macrophages and contain HIV-1 particles [93].  
Figure 2. Simplified model of the immunological synapse and cell-to-cell transfer 
via the virological  synapse  or  through membrane extensions (a) The antigen-presenting 
cell  (APC)-T-cell immunological synapse (IS) is a stable contact. It is mediated by 
peptide-loaded-MHC II on the APC interacting with the TCR on the T-cell, in a central 
region called cSMAC, which is devoid of F-actin. Adhesion molecules ICAM1 on the APC 
and LFA1 on the T-cell surround and stabilize the cSMAC. In turn, talin and F-actin are 
organized into a peripheral ring like structure, the pSMAC. Note that costimulatory 
signaling through CD4/Lck, and TCR signaling leading to T-cell activation are not 
depicted for simplicity. (b) Transfer of HIV-1 between T cells occurs via the virological 
synapse (VS). HIV-1 Env–CD4 interactions result in clustering of CD4/CXCR4, adhesion 
molecules and talin at the cell contact zone, similar to the IS. HIV-1 Env signaling leads to 
partial T-cell activation and creates a central actin-depleted region. HIV-1 assembles 
directly at the VS or is transported to the contact prior to transfer. Fusion takes place 
directly at the target cell membrane or after endocytosis. The formation of the 
immunological and virological synapse are dependent on the actin and microtubule 
cytoskeleton (c) Alternatively, transfer of HIV-1 can take place on actin-containing 
membrane extensions: filopodial bridges or nanotubes. Filopodial bridges extend from 
uninfected to infected cells and transport receptor-bound virions through retrograde 
actin-flow. Nanotubes connect uninfected and infected cells and transport virions in an 
Env-independent manner.  
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Figure 2. Cont. 
 
 
Recently, the relative contributions of virological synapses, nanotubes and filopodial bridges to 
HIV-1 transfer between T cells were quantified. The authors found less than 10% of transfer occurring 
on nanotubes or filopodia with main contributions to viral transfer made by virological synapses [80]. 
Another study found 30–50% of T cells connected through nanotubes and approximately half of these 
structures were associated with HIV-1 Gag [92].  
Live-cell microscopy visualized transfer of viral particles on nanotubes occurred with 0.08 µm/s, on 
filopodial bridges with 0.01 µm/s and into VS with 0.1–0.25 µm/s [91,92]. The different movement of 
viral particles can reflect diffusion, drift, confinements or use of distinct motor proteins and interaction 
with the underlying cytoskeleton in different cells [90]. Alternatively, the proximity of filopodia 
bridges to the glass surface and 3D matrix used to stabilize nanotubes may affect the viral movements. 
Therefore, the relative contributions of different cell-to-cell transfer mechanisms should be carefully 
examined under in vivo conditions in lymphatic tissue. Of note, clusters of SIV-positive cells were 
found in vaginal and lymph node tissue of macaques, indicating effective transfer between T cells, 
albeit the sensitivity and resolution of this technique limit detailed interpretation [80]. 
HIV-1 Nef was shown to remodel the actin cytoskeleton in infected lymphocytes leading to 
impaired migration in response to cytokines, inhibition of membrane ruffles and induction of 
filopodia-like protrusions [94,95] and reviewed in [96]. Overall reduced mobility and protrusions 
could enhance cell-to-cell transfer. Conversely, HIV-1 Nef modestly increased cell-to-cell transfer in 
lymphocytes without affecting actin remodeling in virological synapses and nanotubes [97]. Increased 
cell-to-cell transfer was attributed to a positive effect of Nef on infectivity [97].  
Similarly, infected macrophages formed Nef-dependent long range intercellular protrusions 
with  B  cells that induced antibody class switching, leading to decreased virus-specific antibody 
responses [98]. The effects of Nef on cell mobility and communication between immune cells are 
discussed in a review by Stolp and Fackler in this issue [96].  
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4. Role of the Cytoskeleton in Virological Synapses between DCs and T Cells 
DCs participate in the early HIV-1 dissemination in mucosal and lymphatic tissue [69,70,99]. 
Immature DCs bind, internalize and degrade extracellular material into peptides that can be presented 
on MHC complexes. Potential pathogens, like viruses and bacteria are recognized by pattern 
recognition receptors and can lead to DC maturation. During maturation DCs decrease endocytosis and 
upregulate chemokine-receptors and co-stimulatory proteins (CD80, CD83 and CD86). While 
maturating, DCs migrate to lymph nodes, where they present antigens to T cells and B cells. HIV-1 
exposure does not lead to DC maturation [67,100], except when high doses of virus are used or when 
high infection rates are achieved in the presence of SIV vpx [101,102].  
The initial maturation state of DCs upon contact has significant impact on HIV-1 infection and 
transfer [70,99] 
While both immature DCs (iDCs) and mature DCs (mDCs) efficiently capture HIV-1, mDCs 
transfer virions more efficiently to T cells [73,76,103]. Alternatively, HIV-1 can infect iDCs more 
efficiently than mDCs and transfer newly replicated virus to T cells [70,72]. Overall, cell-to-cell 
transfer from DCs to T cells occurs in two phases, first transfer of captured virus occurs within 24 h 
after exposure and later newly replicated virus is transferred [73].  
Following capture, HIV-1 alters endolysosomal trafficking of DCs and localizes to surface 
accessible compartments that contain tetraspanins and actin, but lack MHCII (Figure 3) 
[35,36,67,104,105]. Upon contact with CD4 T cells a VS is formed: viral proteins and tetraspanins 
polarize on the DC side, while CD4, CXCR4/CCR5 and LFA-1 concentrate on the target T-cell 
[36,76]. Subsequent live cell imaging of the transfer from DCs and macrophages revealed dynamic 
translocation of HIV-1 containing compartments towards the contact zone and transfer of individual 
virions toward T cells [35,106,107].  
Inhibition of actin remodeling in DCs pulsed with HIV-1 inhibited VS formation and transfer to T 
cells [34,104,107]. Therefore, actin remodeling could control trafficking of internal compartments 
and/or cell surface structures involved in HIV-1 DC T cell transfer.  
Recent ultra-structural work revealed that HIV-1 pulsed mDCs form extensive actin-containing 
membrane sheets around T cells. HIV-1 localizes to internal compartments in mDCs and on membrane 
protrusions of T cells that reach into the virus containing compartments [104].  
This analysis suggests that efficient viral transfer at the highly secluded mDC-T cell virological 
synapse depends on actin-containing membrane extensions. The molecular mechanisms of VS 
formation and actin remodeling in mDC T-cell transfer remain to be discovered.  
DC-SIGN specifically binds HIV-1 through Env, localizes to the VS and is required for targeting of 
HIV-1 from an internal compartment to the VS and for transfer of infection [76,108].  
DC-SIGN engagement with antibodies induces signaling in DC: Both ERK and Rho-GTPase, but 
not Rac-GTPase become activated and modulate DC maturation, cytokine release and T-cell 
contacts [109,110]. Specifically, HIV-1 binding to DC-SIGN activates the Rho Guanine Exchange 
Factor (GEF) Larg that is required for VS formation and transfer [110]. Rho-GTPases control 
actin-dynamics during cell migration, IS formation and were proposed to affect dendrite formation in 
DCs [79,110]. 
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Figure 3. ( a) Dendritic cells (DCs) interact with HIV-1 via DC-SIGN and capture 
infectious virus inside endosome-like compartments and surface accessible pockets in an 
actin and microtubule dependent manner. (b) Interaction of HIV-1 Env with DC-SIGN (i) 
activates Larg/Rho signaling to establish DC T-cell contacts, (ii) activates Cdc42 to induce 
membrane extensions, and (iii) preserves an immature DC phenotype. (c, d) Transfer of 
HIV-1 at DC-T cell VS occurs at cell contact zones enriched in HIV-1 receptor/coreceptor, 
adhesion molecules, tetraspanins and actin. (c) Specifically transfer from iDCs occurs on 
actin containing and Cdc42 dependent membrane extensions, (d) conversely, mDCs wrap 
large membrane sheets around T cells forming the virological synapse. HIV-1 was found 
on mDC membrane sheets and on thin membrane extensions from the T cells reaching into 
virus containing compartments. 
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Recently, we used systematic siRNA knockdowns of cytoskeleton modulators like GEF, 
Rho-GTPases and formins in iDCs to identify pathways required for HIV-1 uptake, trafficking and 
transfer at the iDC-T-cell VS [107]. HIV-1 induced the formation of membrane-extensions in iDCs 
through Env binding to DC-SIGN and subsequent activation of the Rho GTPase Cdc42. Notably both 
CXCR4 and the CCR5 Env protein that mediates infection of macrophages and DCs activate 
Cdc42  and induce membrane extensions in iDCs. Knockdown, pharmacological inhibition and 
dominant-negative constructs targeting Cdc42 reduced the number of membrane extensions and HIV-1 
transfer to target T cells. In iDCs fluorescent HIV-1 particles were found on dynamic membrane 
extensions involved in transfer across VS. Notably, when contacts between iDCs and T cells were 
increased by promoting IS or at high T to DC cell ratio, as found in lymph nodes, we observed that 
most of the HIV-1 transfer was mediated by Cdc42-dependent membrane extensions. 
HIV-1 infected iDCs showed polarized budding and transfer of viral particles on dendrites towards 
target cells [67]. How HIV-1 infection of DCs affects actin remodeling, membrane extension and VS 
formation in detail remains to be determined. 
5. Conclusions and Perspectives 
During its replication cycle, HIV-1 remodels cytoskeleton structures using different viral proteins. 
Upon binding to cells, HIV-1 Env induces actin remodeling to concentrate receptor/coreceptors, 
initiate fusion and overcome the plasma membrane cortical actin network. HIV-1 entry through 
endocytosis and transport of its genome on actin or microtubules largely depends on the cell type. 
Polarized budding and cell-to-cell transfer in primary cells, but not HIV-1 assembly and release, 
depend on the cytoskeleton. HIV-1 uses different actin-containing structures to spread efficiently 
between T cells and from APCs to T cells: virological synapses, filopodial bridges, nanotubes, 
tunneling nanotubes and membrane extensions. A detailed mechanism for Env-induced actin 
remodeling at the VS is still missing. HIV-1 binding to DC-SIGN affects DC maturation, actin 
remodeling and induction of membrane extension in the context of DC-T cell VS.  
How virological synapses and different actin-containing cell surface structures contribute to in vivo 
spread of HIV-1 remains a challenging question for the future.  
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